Abstract
Nuclear medicine studies have a role in the evaluation of drug induced osteonecrosis of the jaw (DIONJ). In this article, we discuss the current and future applications within nuclear medicine appropriate for evaluation of DIONJ. The emphasis of this article is positron emission tomography (PET) imaging, specifically, with 18F-fluoro-deoxy-glucose (FDG).
Original language | English (US) |
---|---|
Pages (from-to) | 239-245 |
Number of pages | 7 |
Journal | Oral and Maxillofacial Surgery Clinics of North America |
Volume | 26 |
Issue number | 2 |
DOIs | |
State | Published - Jan 1 2014 |
Keywords
- Drug-induced osteonecrosis of the jaw (DIONJ)
- FDG
- Nuclear medicine imaging
- PET/CT
ASJC Scopus subject areas
- Surgery
- Otorhinolaryngology
- Oral Surgery